Evotec SE (EVOTF) Net Margin (2020 - 2025)
Evotec SE's (EVOTF) quarterly Net Margin came in at 34208.36% in Q4 2025, up 5340416.0% year-on-year from N/an in Q4 2024, and down 130400.58% quarter-over-quarter from 26.21% in Q3 2025.
Evotec SE (EVOTF) Net Margin (2020 - 2025) Analysis & Trends
Evotec SE has disclosed Net Margin across 6 years of filings, most recently posting 34208.36% for Q4 2025.
- Net Margin for Q4 2025 came in at 34208.36%, up 5340416.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 10899.43% (up 531847.0% YoY), and the FY2025 annual result was 13.13%, up 2460211987.0% from the prior year.
- Net Margin came in at 34208.36% for Q4 2025 at Evotec SE, down from 26.21% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 49949.3% in Q4 2021 to a low of 87612.52% in Q4 2024.
- The 5-year median for Net Margin is 16.22% (2022), against an average of 8043.92%.
- Across the five-year window, Net Margin plunged 120216699 bps in 2021 and jumped 5340416 bps in 2025, its largest moves.
- Evotec SE's Net Margin stood at 49949.3% in 2021, then slumped by 169 bps to 34420.04% in 2022, then surged by 58 bps to 14457.12% in 2023, then plunged by 506 bps to 87612.52% in 2024, then surged by 61 bps to 34208.36% in 2025.
- The last three Net Margin figures came in at 34208.36% (Q4 2025), 26.21% (Q3 2025), and 87612.52% (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 9.19% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 26.57% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 35.18% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 2.94% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 24.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 4.16% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -168.42% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.15% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 31.38% |
| 10 | Evotec SE | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -34,208.36% |
| Sep 30, 2025 | -26.21% |
| Dec 31, 2024 | -87,612.52% |
| Sep 30, 2024 | -25.35% |
| Dec 31, 2023 | -14,457.12% |
| Sep 30, 2023 | 19.85% |
| Jun 30, 2023 | -12.00% |
| Dec 31, 2022 | -34,420.04% |
| Sep 30, 2022 | 27.19% |
| Jun 30, 2022 | -16.22% |
| Mar 31, 2022 | -44.48% |
| Dec 31, 2021 | 49,949.30% |
| Sep 30, 2021 | 84.10% |
| Jun 30, 2021 | 43.42% |
| Mar 31, 2021 | 39.60% |
| Dec 31, 2020 | 1,252,116.29% |